Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
MWN-AI** Summary
Univar Solutions LLC has been appointed as the distributor for Ingredion Pharma Solutions in the United States and Canada, particularly focusing on pharmaceutical starches. This agreement allows Univar to exclusively distribute Ingredion’s extensive portfolio of functional excipients, including direct compression and wet granulation binders, tablet fillers, and vegetarian softgel gelatin replacements. The move is designed to bolster Univar’s offerings in the pharmaceutical and nutraceutical sectors, enhancing their capability to address formulation challenges faced by manufacturers.
Aaron Lee, Global Senior Vice President of Health & Nutrition at Univar Solutions, expressed enthusiasm about this partnership, highlighting the benefits it brings to pharmaceutical and nutraceutical customers. By expanding access to a variety of functional excipients, Univar aims to help businesses grow and innovate within the rapidly evolving market.
Ingredion, a global provider of ingredient solutions, manufactures a range of functional ingredients intended to improve formulation efficacy. Joe Rogus, Pharma Senior Sales Manager for Ingredion, noted the strategic nature of this collaboration, citing Univar's strong track record in delivering high-value specialty products and services to the pharmaceutical market.
The alliance not only deepens the bond between both companies but also emphasizes Univar's commitment to sustainability, quality, and technical support, which are vital in navigating the complexities of the ingredient distribution industry. As a leading distributor with a robust logistics network and expertise, Univar Solutions is poised to enhance formulation performance and innovation across pharmaceutical applications in North America.
MWN-AI** Analysis
Univar Solutions' selection as the distributor for Ingredion Pharma Solutions in the U.S. and Canada marks a strategic advancement for both companies, with significant implications for investors and stakeholders in the pharmaceutical and nutraceutical sectors. This partnership will allow Univar to enhance its product offerings significantly, particularly in pharmaceutical-grade starches and functional excipients, which are crucial in formulation development.
From an investor's perspective, this agreement presents a favorable opportunity. Univar Solutions will likely benefit from increased sales and enhanced market positioning due to its exclusive distribution rights. The extensive distribution network already established by Univar, combined with Ingredion's innovative product portfolio, can facilitate broader market penetration and customer acquisition. Pharmaceutical manufacturers will now have access to a diverse range of high-quality ingredients that could drive efficiency in product development, which is essential amidst regulatory pressures and evolving consumer preferences.
Moreover, this collaboration is timely as the global pharmaceutical market continues to expand, driven by advancements in drug formulation and increasing healthcare demands. Investors should pay close attention to Univar's financial disclosures post-agreement to evaluate how this partnership translates into revenue growth and market share capture.
That said, potential investors should also consider the inherent risks involved, including supply chain challenges, regulatory hurdles, and market competition. It will be critical for Univar to maintain high standards of quality and customer service to leverage this opportunity fully. Overall, the strategic partnership between Univar Solutions and Ingredion presents a compelling case for investment, positioning both companies to thrive in a rapidly evolving pharmaceutical landscape. Keeping an eye on future performance metrics and market developments is advisable for making informed investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients
DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR). The agreement includes distribution of Ingredion's global pharmaceuticals portfolio and positions the Company as the exclusive distributor of pharmaceutical starches in the United States and Canada. This strategic partnership enables Ingredients + Specialties to further diversify and strengthen its pharmaceutical and nutraceutical ingredients portfolios with a broad range of functional excipients, including direct compression and wet granulation binders, fillers for tablets and capsules, superdisintegrants, lubricants, emulsion for encapsulation, and gelatin replacements for vegetarian softgel formulations.
"We are thrilled to enhance our product range while deepening our partnership with Ingredion," said Aaron Lee, global senior vice president of Health & Nutrition for Univar Solutions. "Through this agreement, we will expand access to pharmaceutical starches and other functional excipients in the United States and Canada, helping our pharmaceutical and nutraceutical customers address formulation challenges and grow their businesses. This partnership truly underscores our commitment connecting customers to high-quality ingredients and customized market solutions, and we are optimistic that the collaboration will help enhance tableting, softgel, and encapsulation applications."
Ingredion Pharma Solutions, part of Ingredion, a global ingredient solutions provider, produces functional ingredients, including pharmaceutical-grade starches designed to enhance formulation performance and help overcome the technical challenges experienced in various pharmaceutical and nutraceutical applications. Through the agreement, Ingredients + Specialties from Univar Solutions will distribute Ingredion's pharma portfolio and is the exclusive distributor in the United States and Canada for the Pharma starch-based excipients including UNI-PURE® F, UNI-PURE® FL, UNI-PURE® GA, and UNI-PURE® WG-220.
"We are excited to expand our partnership with Ingredients + Specialties from Univar Solutions in the pharmaceutical starches, mannitol, and specialty excipients product space," said Joe Rogus, pharma senior sales manager – United States and Canada for Ingredion. "They are a world-class organization with an excellent track record in delivering high-value specialty products and services to pharmaceutical markets. We're confident that this collaboration will drive ingredient innovation and deliver exceptional value to our customers."
The Ingredients + Specialties portfolio from Univar Solutions—one of the most trusted names in innovation and distribution—offers the essential specialty ingredients needed for brands and manufacturers to develop new and improved products that deliver results for their customers. The portfolio is backed by their commitment to innovation, sustainability, and quality, as well as technical support and formulation expertise to help ensure customers and suppliers are equipped to navigate the industry's rapidly changing future with confidence and creativity.
Explore how the relationship between Ingredients + Specialties from Univar Solutions and Ingredion Pharma Solutions enhances formulation performance and addresses technical challenges.
About Univar Solutions
Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.
About Ingredients + Specialties from Univar Solutions
Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at?univarsolutions.com.
About Ingredion Pharma Solutions
Ingredion Incorporated (NYSE: INGR) is a global innovative ingredient solutions provider. For Pharma & Nutraceuticals, we partner with customers seeking functional materials to enhance the performance of formulations and overcome their technical challenges. Our solutions include binders, fillers, superdisintegrants, lubricants, plasticizer, gelatine replacers for veggie softgel, emulsions for encapsulation, and parenteral APIs. We are in the continuous transformation to combine cGMP facilities, regulatory assistance, global presence, and technical support to be a trusted formulation problem-solving partner to our customers. To learn more, access ingredionpharma.com/
Forward-Looking Statements and Information
This communication contains "forward-looking statements" under applicable law regarding financial and operating items relating to the Company's business. Forward-looking statements generally can be identified by words such as "believes," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates," "anticipates" or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.
Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company's business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company's most recent annual report and other financial reports, including the information set forth under the caption "Risk Factors." Any forward-looking statements represent the Company's views only as of the date of this communication and should not be relied upon as representing the Company's views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.
SOURCE Univar Solutions LLC
FAQ**
How will Univar Solutions leverage its extensive distribution network to optimize the delivery of Ingredion Incorporated INGR's pharmaceutical starches and excipients in the United States and Canada?
What specific benefits do you anticipate for pharmaceutical manufacturers utilizing Ingredion Incorporated INGR's functional excipients distributed by Univar Solutions?
Can you detail the technical support and formulation expertise that Univar Solutions will provide to customers as they adopt Ingredion Incorporated INGR's products?
How does this partnership with Ingredion Incorporated INGR position Univar Solutions for future growth in the pharmaceutical and nutraceutical markets?
**MWN-AI FAQ is based on asking OpenAI questions about Ingredion Incorporated (NYSE: INGR).
NASDAQ: INGR
INGR Trading
1.14% G/L:
$117.945 Last:
129,538 Volume:
$117.14 Open:
